Investors & Media

Press Releases

View all press releases »

Ionis to hold first quarter 2024 financial results webcast

April 23, 2024 at 7:05 AM EDT

Webcast scheduled for Tuesday, May 7 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., April 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, May 7th at 11:30 a.m. Eastern Time to discuss its first quarter 2024 financial results.

The webcast may be accessed at A replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis visit and follow us on Twitter @ionispharma.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley – 760-603-4679

Cision View original content to download multimedia:

SOURCE Ionis Pharmaceuticals, Inc.